These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11086225)

  • 21. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
    J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roads from vaccines to therapies.
    Smith LA; Jensen MJ; Montgomery VA; Brown DR; Ahmed SA; Smith TJ
    Mov Disord; 2004 Mar; 19 Suppl 8():S48-52. PubMed ID: 15027054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors.
    Yu Y; Yu J; Li N; Wang S; Yu W; Sun Z
    Vaccine; 2009 Oct; 27(44):6148-53. PubMed ID: 19712769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen.
    Gao YL; Gao S; Kang L; Nie C; Wang JL
    Hum Vaccin; 2010 Jun; 6(6):462-6. PubMed ID: 20519939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intradermal immunization with botulinum neurotoxin serotype E DNA vaccine induces humoral and cellular immunity and protects against lethal toxin challenge.
    Kim NY; Ahn HB; Yu CH; Song DH; Hur GH; Shin YK; Shin S
    Hum Vaccin Immunother; 2019; 15(2):412-419. PubMed ID: 30235058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine.
    Yu YZ; Li N; Wang RL; Zhu HQ; Wang S; Yu WY; Sun ZW
    Clin Vaccine Immunol; 2008 Dec; 15(12):1819-23. PubMed ID: 18845829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum neurotoxin vaccines: Past history and recent developments.
    Rusnak JM; Smith LA
    Hum Vaccin; 2009 Dec; 5(12):794-805. PubMed ID: 19684478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective efficacy of recombinant bacterin vaccine against botulism in cattle.
    Moreira C; Ferreira MRA; Finger PF; Magalhães CG; Cunha CEP; Rodrigues RR; Otaka DY; Galvão CC; Salvarani FM; Moreira ÂN; Conceição FR
    Vaccine; 2020 Mar; 38(11):2519-2526. PubMed ID: 32037222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of immunodetection system for botulinum neurotoxin serotype E.
    Sarita R; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Indian J Med Res; 2018 Jun; 147(6):603-610. PubMed ID: 30168493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge.
    Scott VL; Villarreal DO; Hutnick NA; Walters JN; Ragwan E; Bdeir K; Yan J; Sardesai NY; Finnefrock AC; Casimiro DR; Weiner DB
    Hum Vaccin Immunother; 2015; 11(8):1961-71. PubMed ID: 26158319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What next for botulism vaccine development?
    Webb RP; Smith LA
    Expert Rev Vaccines; 2013 May; 12(5):481-92. PubMed ID: 23659297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines against Botulism.
    Sundeen G; Barbieri JT
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28869493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and preclinical evaluation of a new F(ab')₂ antitoxin against botulinum neurotoxin serotype A.
    Yu YZ; Zhang SM; Wang WB; Du Y; Zhu HQ; Wang RL; Zhou XW; Lin JB; Wang S; Yu WY; Huang PT; Sun ZW
    Biochimie; 2010 Oct; 92(10):1315-20. PubMed ID: 20600570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of a Bivalent Non-Purified Recombinant Vaccine against Botulism in Cattle.
    Moreira C; Ferreira MRA; da Cunha CEP; Donassolo RA; Finger PF; Moreira GMSG; Otaka DY; de Sousa LA; Barbosa JD; Moreira ÂN; Salvarani FM; Conceição FR
    Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30241350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High level expression, purification and immunogenicity analysis of a protective recombinant protein against botulinum neurotoxin type E.
    Valipour E; Moosavi ML; Amani J; Nazarian S
    World J Microbiol Biotechnol; 2014 Jun; 30(6):1861-7. PubMed ID: 24469548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles.
    Ruwona TB; Xu H; Li J; Diaz-Arévalo D; Kumar A; Zeng M; Cui Z
    Hum Vaccin Immunother; 2016 May; 12(5):1188-92. PubMed ID: 26837242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High level expression and immunochemical characterization of botulinum neurotoxin type F light chain.
    Chauhan R; Chauhan V; Rao MK; Chaudhary D; Bhagyawant S; Dhaked RK
    Protein Expr Purif; 2018 Jun; 146():51-60. PubMed ID: 29407166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E.
    Mukamoto M; Maeda H; Kohda T; Nozaki C; Takahashi M; Kozaki S
    Jpn J Infect Dis; 2013; 66(1):46-50. PubMed ID: 23429085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
    Lee JS; Groebner JL; Hadjipanayis AG; Negley DL; Schmaljohn AL; Welkos SL; Smith LA; Smith JF
    Vaccine; 2006 Nov; 24(47-48):6886-92. PubMed ID: 16828936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F H(C) fragment.
    Foynes S; Holley JL; Garmory HS; Titball RW; Fairweather NF
    Vaccine; 2003 Mar; 21(11-12):1052-9. PubMed ID: 12559779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.